Antithrombotic therapy in atrial fibrillation with ximelagatran:  can it be an alternative to warfarin?

Kıraç, Suna

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes
In titles and abstracts
In keywords
In all

pdf

Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin? [Anatol J Cardiol]

Anatol J Cardiol. 2007; 7(2): 214-215

Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?

Suna Kıraç¹
Pamukkale Üniversitesi Tıp Fakültesi Nükleer Tıp Anabilim Dalı, Denizli, Türkiye

Atriyal fibrilasyonda ximelagatran ile antitrombotik tedavi: Ximelagatran warfarin’e alternatif olabilir mi?

Suna Kıraç¹
Pamukkale Üniversitesi Tıp Fakültesi Nükleer Tıp Anabilim Dalı, Denizli, Türkiye

Suna Kıraç. Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?. Anatol J Cardiol. 2007; 7(2): 214-215
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Similar articles PubMed Google Scholar

Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

Quick Search

In authors and institutes
In titles and abstracts
In keywords
In all